CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company
TENAX THERAPEUTICS, INC.
Sign in to watch- Ticker
- TENX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262593535
- Phone
- 919-855-2100
- Business address
- 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
- Former names
- OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
- 8-K Event Shareholder vote results
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- SC 13G/A Stake Amended Statement of Ownership
- 4 Returned to the company CFO returned 98 shares (to the company)
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market buy Director bought 12,950 shares at an average $0.45 ($5,887)
- 4 Open-market sale Director sold 12,950 shares at $0.39 ($5,051)
- 10-Q Report Quarterly Report
- 8-K Event Delisting notice
- 10-Q Report Quarterly Report
- 4 Returned to the company CFO returned 54 shares (to the company)
- 8-K Event Other events
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- 4 Returned to the company CFO returned 56 shares (to the company)
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
Page 25 of 50 · 996 filings